← Leaderboards
Timothy C Chambers
University Of Arkansas Med Scis Ltl Rock
$3,739,446
Attributed
$3,739,446
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $445.9K · FY2005–14$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$3,739,446 · 3
By mechanism
R01$3,739,446 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisPhosphorylationVinblastineProtein Protein InteractionNeoplasm /Cancer ChemotherapyPhosphotransferasesPharmacokineticsTissue /Cell CultureMicrotubulesCellsAntineoplastic AgentsInhibitor/AntagonistAntineoplasticsBaseInsightIn VivoImmunocytochemistryBiological Signal TransductionEventLinkAp1 ProteinGene ExpressionDrug Effect DisorderCytotoxicity
Grant awards (19)
Bcl-2 Proteins in Mechanism of Anti-mitotic Drug Action$220,391
R01 · FY2014 · CA · contact PI
Prostate tumor progression by mitochondrial DNA change$218,832
R01 · FY2013 · CA · contact PI
Bcl-2 Proteins in Mechanism of Anti-mitotic Drug Action$213,574
R01 · FY2013 · CA · contact PI
Bcl-2 Proteins in Mechanism of Anti-mitotic Drug Action$227,207
R01 · FY2012 · CA · contact PI
Bcl-2 Proteins in Mechanism of Anti-mitotic Drug Action$227,207
R01 · FY2011 · CA · contact PI
Bcl-2 Proteins in Mechanism of Anti-mitotic Drug Action$234,234
R01 · FY2010 · CA · contact PI
BcL-2 Proteins in Mechanism of Anti-mitotic Drug Action$220,813
R01 · FY2008 · CA · contact PI
BcL-2 Proteins in Mechanism of Anti-mitotic Drug Action$220,813
R01 · FY2007 · CA · contact PI
BcL-2 Proteins in Mechanism of Anti-mitotic Drug Action$227,407
R01 · FY2006 · CA · contact PI
BcL-2 Proteins in Mechanism of Anti-mitotic Drug Action$232,880
R01 · FY2005 · CA
Stress-activated Protein Kinases and Chemotherapy$213,000
R01 · FY2005 · CA
BcL-2 Proteins in Mechanism of Anti-mitotic Drug Action$253,380
R01 · FY2004 · CA
Stress-activated Protein Kinases and Chemotherapy$213,000
R01 · FY2004 · CA
Stress-activated Protein Kinases and Chemotherapy$213,000
R01 · FY2003 · CA
Stress-activated Protein Kinases and Chemotherapy$41,408
R01 · FY2003 · CA
Stress-activated Protein Kinases and Chemotherapy$20,642
R01 · FY2003 · CA
Stress-activated Protein Kinases and Chemotherapy$202,500
R01 · FY2002 · CA
STRESS ACTIVATED PROTEIN KINASES AND CHEMOTHERAPY$172,086
R01 · FY2001 · CA
STRESS ACTIVATED PROTEIN KINASES AND CHEMOTHERAPY$167,072
R01 · FY2000 · CA